Schizophrenia

• 11/15/2024

  AbbVie’s Schizophrenia Treatment Fails: What’s Next?

• 11/13/2024

  AbbVie’s Schizophrenia Drug Fails, Bristol Myers Squibb Gains Edge

• 10/2/2024

  **Neurocrine Biosciences Play**

• 9/28/2024

  **FDA Approves Groundbreaking Schizophrenia Treatment**